Uscom Ltd

Uscom granted medical device sales certification in China

The medical technology company specialises in the development and marketing of premium non-invasive cardiovascular and pulmonary medical devices.

USCOM 1A is a non-invasive haemodynamic monitor

Uscom Ltd’s (ASX:UCM) Chinese subsidiary has been granted a Type II Medical Device Business Registration Certificate in China.

Uscom China can now sell all type II medical devices including USCOM 1A, Uscom BP+ and SpiroSonic digital ultrasonic spirometers, directly into the Chinese market.

While all current Uscom business in China is based on USCOM 1A sales, Uscom currently has USCOM 1A in a re-approval cycle, and the Uscom BP+ and the SpiroSonic series of devices in their initial Chinese NMPA regulatory process.

This new certification provides a platform for the direct sale of these devices following the completion of these regulatory approvals.

Building a long-term business in China

Uscom China now has a registered Beijing office with a Business License, a Foreign Trade Registration Record, a VAT General Taxpayer Qualification Form, a Certificate of Customs Declaration and full capital and trading bank facilities.

Uscom executive chairman Associate Professor Rob Phillips said: “We are not just selling products into China, we are building a long-term business in China based on a new business model.

“Following this certification we can now import, support and sell medical devices independently as we bring our seven new products to the Chinese market.


“As our NMPA submissions progress, we are preparing by building the on-ground resources to expand operations in the China market.

“We are also focused on expanding our current distribution, to create a wide-reaching sales organisation that can cover the expansive geography of China.”

Quick facts: Uscom Ltd

Price: $0.12

Market: ASX
Market Cap: $15.9 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Uscom Ltd named herein, including the promotion by the Company of Uscom Ltd in any Content on the Site, the Company receives from said issuer...



Uscom 'on the cusp of releasing seven new products into global markets'

Uscom Ltd (ASX:UCM) founder, chairman and chief executive Rob Phillips speaks to Proactive Investors about the cardiovascular-pulmonary medical device producer's expanding global operations and product offering. The company is obtaining final approvals to launch new products in Australia,...

on 10/7/18

2 min read